Murine protein kinase CK2α': cDNA and genomic cloning and chromosomal mapping

Genomics

Volumn 48, Issue 1, 1998, Pages 79-86

  Xu, Xin ^a   Rich Jr , Edwin S ^b   Seldin, David C ^a,b  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PROTEIN KINASE C;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CHROMOSOME MAP; GENE EXPRESSION REGULATION; GENETIC LINKAGE; GENOME; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

EID: 0031935977     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1997.5154     Document Type: Article

References (38)

1. Allende J. E., Allende C. C. Protein kinases. 4. Protein kinase CK2: An enzyme with multiple substrates and a puzzling regulation. FASEB J. 9:1995;313-323.
2. Barroga C. F., Stevenson J. K., Schwarz E. M., Verma I. M. Constitutive phosphorylation of I kappa B alpha by casein kinase II. Proc. Natl. Acad. Sci. USA. 92:1995;7637-7641.
3. Berberich S. J., Cole M. D. Casein kinase II inhibits the DNA-binding activity of Max homodimers but not Myc/Max heterodimers. Genes Dev. 6:1992;166-176.
4. Daya-Makin M. M., Sanghera J. S., Mogentale T. L., Lipp M., Parchomchuk J., Hogg J. C., Pelech S. L. Activation of a tumor-associated protein kinase (p40TAK) and casein kinase 2 in human squamous cell carcinomas and adenocarcinomas of the lung. Cancer Res. 54:1994;2262-2268.
5. Edelman A. M., Blumenthal D. K., Krebs E. G. Protein serine/threonine kinases. Annu. Rev. Biochem. 56:1987;567-613.
6. Filhol O., Baudier J., Delphin C., Loue-Mackenbach P., Chambaz E. M., Cochet C. Casein Kinase II and the tumor suppressor protein p53 associate in a molecular complex that is negatively regulated upon p53 phosphorylation. J. Biol. Chem. 267:1992;20577-20583.
7. Gapany M., Faust R. A., Tawfic S., Davis A., Adams G. L., Ahmed K. Association of elevated protein kinase CK2 activity with aggressive behavior of squamous cell carcinoma of the head and neck. Mol. Med. 1:1995;659-666.
8. Goldfarb A. N., Goueli S., Mickelson D., Greenberg J. M. T-cell acute lymphoblastic leukemia - The associated gene SCL/tal codes for a 42-Kd nuclear phosphoprotein. Blood. 80:1992;2858-2866.
9. Gotz C., Wagner P., Issinger O. G., Montenarh M. p21WAF1/CIP1 interacts with protein kinase CK2. Oncogene. 13:1996;391-398.
10. Hanna D. E., Rethinaswamy A., Glover C. V. Casein kinase II is required for cell cycle progression during G1 and G2/M inSaccharomyces cerevisiae. J. Biol. Chem. 270:1995;25905-25914.
11. Hathaway G. M., Traugh J. A. Casein kinases - Multipotential protein kinases. Curr. Top. Cell Regul. 21:1982;101-127.
12. Hu E., Rubin C. S. Casein kinase II fromCaenorhabditis elegans. J. Biol. Chem. 265:1990;5072-5080.
13. Jain N., Mahendran R., Philp R., Guy G. R., Tan Y. H., Cao X. Casein kinase II associates with Egr-1 and acts as a negative modulator of its DNA binding and transcription activities in NIH 3T3 cells. J. Biol. Chem. 271:1996;13530-13536.
14. Johnson S. E., Wang X., Hardy S., Taparowsky E. J., Konieczny S. F. Casein kinase II increases the transcriptional activities of MRF4 and MyoD independently of their direct phosphorylation. Mol. Cell. Biol. 16:1996;1604-1613.
15. Kelliher M. A., Seldin D. C., Leder P. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase II alpha. EMBO J. 15:1996;5160-5166.
16. Kikawa U., Mann S. K., Firtel R. A., Hunter T. Molecular cloning of casein kinase II alpha subunit fromDictyostelium discoideum. Mol. Cell. Biol. 12:1992;5711-5723.
17. Larsen F., Gundersen G., Lopez R., Prydz H. CpG islands as gene markers in the human genome. Genomics. 13:1992;1095-1107.
18. Lin A., Frost J., Deng T., Smeal T., Al A. N., Kikkawa U., Hunter T., Brenner D., Karin M. Casein kinase II is a negative regulator of c-Jun DNA binding and AP-1 activity. Cell. 70:1992;777-789.
19. Litchfield D. W., Luscher B. Casein kinase II in signal transduction and cell cycle regulation. Mol. Cell. Biochem. 128:1993;187-199.
20. Lodie T. A., Savedra R. J., Golenbock D. T., Van B. C., Maki R. A., Fenton M. J. Stimulation of macrophages by lipopolysaccharide alters the phosphorylation state, conformation, and function of PU.1 via activation of casein kinase II. J. Immunol. 158:1997;1848-1856.
21. Lozeman F. J., Litchfield D. W., Piening C., Takio K., Walsh K. A., Krebs E. G. Isolation and characterization of human cDNA clones encoding the alpha and the alpha' subunits of casein kinase II. Biochemistry. 29:1990;8436-8447.
22. Luscher B., Christenson E., Litchfield D. W., Krebs E. G., Eisenman R. N. Myb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activation. Nature. 344:1990;517-522.
23. Maridor G., Park W., Krek W., Nigg E. A. Casein kinase II. cDNA sequences, developmental expression, and tissue distribution of mRNAs for alpha, alpha', and beta subunits of the chicken enzyme. J. Biol. Chem. 266:1991;2362-2368.
24. McElhinny J. A., Trushin S. A., Bren G. D., Chester N., Paya C. V. Casein kinase II phosphorylates I kappa B alpha at S-283, S-289, S-293, and T-291 and is required for its degradation. Mol. Cell. Biol. 16:1996;899-906.
25. Padmanabha R., Chen W. J., Hanna D. E., Glover C. V. Isolation, sequencing, and disruption of the yeast CKA2 gene: Casein kinase II is essential for viability inSaccharomyces cerevisiae. Mol. Cell. Biol. 10:1990;4089-4099.
26. Podust V., Bialek G., Sternbach H., Grosse F. Casein kinase II phosphorylates DNA-polymerase-alpha-DNA-primase without affecting its basic enzymic properties. Eur. J. Biochem. 193:1990;189-193.
27. Pugh B. F., Tjian R. Mechanism of transcriptional activation by Sp1: Evidence for coactivators. Cell. 61:1990;1187-1197.
28. Rihs H. P., Jans D. A., Fan H., Peters R. The rate of nuclear cytoplasmic protein transport is determined by the casein kinase II site flanking the nuclear localization sequence of the SV40 T-antigen. EMBO J. 10:1991;633-639.
29. Roussou I., Draetta G. TheSchizosaccharomyces pombe. Mol. Cell. Biol. 14:1994;576-586.
30. Rowe, L. B. Nadeau, J. H. Turner, R. Frankel, W. N. Letts, V. A. Eppig, J. T. Ko, M. S. Thurston, S. J. Birkenmeier, E. H. 1994, Maps from two interspecific backcross DNA panels available as a community genetic mapping resource, Mamm. Genome, 5, 253, 274, Mamm. Genome, 5, 463.
31. Sehgal A., Patil N., Chao M. A constitutive promoter directs expression of the nerve growth factor receptor gene. Mol. Cell. Biol. 8:1988;3160-3167.
32. Seldin D. C. New models of lymphoma in transgenic mice. Curr. Opin. Immunol. 7:1995;665-673.
33. Seldin D. C., Leder P. Casein kinase II alpha transgene-induced murine lymphoma: Relation to theileriosis in cattle. Science. 267:1995;894-897.
34. Snell V., Nurse P. Genetic analysis of cell morphogenesis in fission yeast - a role for casein kinase II in the establishment of polarized growth. EMBO J. 13:1994;2066-2074.
35. Wada T., Takagi T., Yamaguchi Y., Kawase H., Hiramoto M., Ferdous A., Takayama M., Lee K. A., Hurst H. C., Handa H. Copurification of casein kinase II with transcription factor ATF/E4TF3. Nucleic Acids Res. 24:1996;876-884.
36. Weis L., Reinberg D. Transcription by RNA polymerase II: Initiator-directed formation of transcription-competent complexes. FASEB J. 6:1992;3300-3309.
37. Wirkner U., Voss H., Lichter P., Ansorge W., Pyerin W. The human gene (CSNK2A1) coding for the casein kinase II subunit alpha is located on chromosome 20 and contains tandemly arranged Alu repeats. Genomics. 19:1994;257-265.
38. Yang-Feng T. L., Naiman T., Kopatz I., Eli D., Dafni N., Canaani D. Assignment of the human casein Kinase II α′ subunit gene (CSNK2A1) to chromosome 16p13.2-p13.3. Genomics. 19:1994;173.